Beyond Glucose Monitoring: Multianalyte Sensor Use in Diabetes.

The incidence, prevalence, mortality, and health expenditure associated with diabetes continue to grow, despite efforts. Use of multianalyte sensors which detect glucose as well as key analytes such as ketones, lactate, insulin, uric acid, and electrolytes, may provide additional information to guide earlier identification and management of diabetes and its complications. We undertook a narrative review using a systematic approach in May 2023, with a bridge search undertaken in April 2024. Four biomedical databases were searched: MEDLINE (Ovid), Embase, Emcare, and Cochrane Library. Searches for grey literature were conducted in ClinicalTrials.gov, Google Scholar, and websites of relevant organisations. Included studies incorporated articles on multianalyte sensors in diabetes and single-analyte sensors proposing integration into multianalyte diabetes management, with no limits placed on publication date and study design. Data were screened and extracted using CovidenceTM software. Overall, 11 articles were included of which eight involved multianalyte sensors (involving glucose and other analytes), and four single-analyte sensors (measuring non-glucose substances for proposed future integration into multianalyte systems). Analytes examined were ketones (n=3); lactate (n=4); uric acid (n=3), insulin (n=1) and potassium (n=1). Results demonstrated that in vitro and in vivo measurements of multi and single-analyte sensors accurately and reliably corresponded with human capillary and serum samples. While literature on this topic is sparse, our review demonstrated that measurement of glucose and other analytes can be feasibly undertaken using multi and single-analyte sensors. More studies in humans are needed to establish clinical utility in diabetes self-management and assist with technological improvements.